Try our Advanced Search for more refined results
November 03, 2008
ELAN PHARMA INTERNATIONAL LTD. et al v. BIOVAIL LABORATORIES INTERNATIONAL SRL et al
Case Number:
2:08-cv-05412
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 04, 2011
Abbott, Elan Drop Tricor IP Suits Against Biovail
Abbott Laboratories and Elan Corp. PLC continued Thursday to wrap up a campaign to block generic versions of the cholesterol drug Tricor, resolving lawsuits against Biovail Corp., which is now owned by Valeant Pharmaceuticals International Inc.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login